C
Cezary Szczylik
Researcher at Medical University of Warsaw
Publications - 291
Citations - 30393
Cezary Szczylik is an academic researcher from Medical University of Warsaw. The author has contributed to research in topics: Renal cell carcinoma & Cancer. The author has an hindex of 49, co-authored 274 publications receiving 27380 citations. Previous affiliations of Cezary Szczylik include Military Medical Academy & Cora.
Papers
More filters
Journal ArticleDOI
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Christophe Massard,J. Zonierek,Marine Gross-Goupil,Karim Fizazi,Cezary Szczylik,Bernard Escudier +5 more
TL;DR: In this subpopulation of patients with metastatic renal cell carcinoma, antiangiogenic therapy, such as sorafenib, could be an effective preventive therapy for brain metastases in advanced RCC.
Journal ArticleDOI
Three-dimensional cell culture model utilization in cancer stem cell research.
Zofia F. Bielecka,Kamila Maliszewska-Olejniczak,Ilan J. Safir,Cezary Szczylik,Anna M. Czarnecka +4 more
TL;DR: Although progress has been made applying 3D technology to CSC research, this technology could be further utilized and a greater number of 3D kits dedicated specifically to C SCs should be implemented.
Journal ArticleDOI
The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench - a critical review.
Jolanta Szenajch,Gabriel Wcisło,Jee-Yeong Jeong,Jee-Yeong Jeong,Cezary Szczylik,Laurie Feldman,Laurie Feldman +6 more
TL;DR: The modulation by rhEPO of tumor cell response to anticancer agents is coincident with modulation of multiple signaling pathways, BCL-2 family proteins, caspases and NFkB.
Journal ArticleDOI
The role of the cell–cell interactions in cancer progression
Katarzyna Kamińska,Cezary Szczylik,Zofia F. Bielecka,Ewa Bartnik,Ewa Bartnik,Camillo Porta,Fei Lian,Anna M. Czarnecka +7 more
TL;DR: This review concentrates on the interactions between stromal and healthy cells from the TME in cancer development and describes mutations, genes and proteins expression pattern that are involved in tumour development in target organ.
Journal ArticleDOI
Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy.
Dawid Sigorski,Paweł Sobczuk,Małgorzata Osmola,Kamil Kuć,Anna Walerzak,Michal Wilk,Tomasz Ciszewski,Sylwia Kopeć,Karolina Hryń,Piotr Rutkowski,Rafał Stec,Cezary Szczylik,Lubomir Bodnar +12 more
TL;DR: For an actively treated patient with cancer, cancer remains the main life-threatening disease during the COVID-19 pandemic and the need for more attentive psychological care should be provided especially to female patients, patients with breast cancer, those under 65 years of age and treated with curative intention, as these factors are associated with a higher level of anxiety.